scholarly journals Medicamentos Não Sujeitos a Receita Médica de Dispensa Exclusiva em Farmácia em Portugal: Uma Oportunidade de Acesso Sub-Aproveitada?

2016 ◽  
Vol 29 (9) ◽  
pp. 542
Author(s):  
Ana Paula Martins ◽  
Elizabete Gonçalves ◽  
Ana Marcelo ◽  
Sergio Vilão ◽  
José Aranda Silva
Keyword(s):  
Public Health ◽  
United Kingdom ◽  
Czech Republic ◽  
Lower Percentage ◽  
Medicinal Products ◽  
Medical Prescription ◽  
Safety And Efficacy ◽  
The Public ◽  
Human Use

Introduction: In 2013 medicinal products for human use not subject to medical prescription dispensed exclusively in pharmacy, a subcategory of products not subject to medical prescription was introduced in Portugal. This category of medicinal products promotes the accessibility to treatment, ensuring safety and efficacy, with benefits to public health. This article analyzed the medicines classified as medicinal products for human use not subject to medical prescription dispensed exclusively in pharmacy or equivalent in seven European countries, United Kingdom, Denmark, Sweden, Norway, Italy, Czech Republic and Portugal, and proposes a preliminary list of common international names/ medicines that possess the characteristics that justify their inclusion in Portugal, in this category.Material and Methods: For the selection, common international names /medicines approved in the considered countries were selected if, in at least one of the countries considered, they are classified as medicinal products for human use not subject to medical prescription dispensed exclusively in pharmacy or equivalent, and/ or have the classification of medicinal products subject to medical prescription in Portugal and medicinal products not subject to medical prescription in one of the considered countries.Results: The preliminary list obtained contains 271 different common international names / presentations. About 19% of the selected common international names do not have a valid marketing authorization in Portugal and the majority (42%) is classified in Portugal as medicinal products not subject to medical prescription, a lower percentage (35%) as medicinal products subject to medical prescription, and only 4% as medicinal products for human use not subject to medical prescription dispensed exclusively in pharmacy.Conclusion: Safety is one of the main aspects to be considered in the context of the reclassification of medicines regarding their supply to the public. The results obtained promote a reflection on the relevance of extending the availability of medicines with the classification of medicinal products for human use not subject to medical prescription dispensed exclusively in pharmacy in Portugal, which, due to their characteristics and indications, would benefit from an access without a medical prescription, ensuring the safety in its use.

scholarly journals Increase in hepatitis A cases in the Czech Republic in 2008 - preliminary report

2008 ◽  
Vol 13 (40) ◽  
Author(s):  
K Fabianova ◽  
J Cástková ◽  
C Beneš ◽  
J Kyncl ◽  
B Kriz
Keyword(s):  
Public Health ◽  
Czech Republic ◽  
Viral Hepatitis ◽  
Preliminary Report ◽  
Hepatitis A ◽  
Health Protection ◽  
The Czech Republic ◽  
The Public ◽  
Viral Hepatitis A ◽  
Public Health Protection

The public health protection authorities in the Czech Republic report a rise in cases of viral hepatitis A (HAV) since the end of May 2008. In total, as many as 602 HAV cases have been reported in 2008 until the end of calendar week 39 (28 September).

scholarly journals ASPHER V4 Working Group supports the road map for professionalising the public health workforce

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
A Petrakova ◽  
R Otok ◽  
V Prikazsky ◽  
M Dlouhy ◽  
Z Prazanova ◽  
...  
Keyword(s):  
Public Health ◽  
Czech Republic ◽  
Health Workforce ◽  
Rapid Assessment ◽  
Public Health Workforce ◽  
The Czech Republic ◽  
The Public ◽  
Road Map ◽  
Current State ◽  
Public Health Profession

Abstract Background The ASPHER V4 Working Group (WG) was established in 2016 and officially launched during the 9th European Public Health Conference in Vienna. One of the key objectives of the WG is to strengthen public health capacity development in V4 countries. The WG supports the implementation of the recently reviewed European Action Plan for Strengthening Public Health Capacities (EAP). The EAP’s review highlighted the need to focus further action on four enabling Essential Public Health Functions (EPHOs) including human resources for public health. This is why the WG is heavily involved in the recent development of a new Road map for professionalising the public health workforce, one of the products of the recently established Coalition of Partners (CoP) that was convened by the WHO Regional Office for Europe in close cooperation with ASPHER and Maastricht University. Objectives Supporting the WHO CoP with a focus on development and further implementation of a new Road map for professionalising public health workforce in V4 countries. Using a new rapid assessment tool to evaluate the state of the public health profession in the Czech Republic. Sharing the report on the current state of public health professions in the Czech Republic with the WG and using it as a comparison of the current state in all V4 countries. Results Key strengths and weaknesses of the first rapid assessment of the current state of the public health profession in the Czech Republic are presented. Key actions are proposed for the WG: a) Preparation of a grant proposal to the International V4 Fund and b) Continuing active involvement in CoP activities. Conclusions The rapid assessment tool for evaluating the state of the public health profession was successfully implemented in the Czech Republic with the close cooperation of academia, researchers, policy makers and practitioners. The summary confirms that further work on the professionalization of the public health workforce is needed. Key messages ASPHER V4 WG is strongly involved in the development of a new road map for professionalising the public health workforce, coordinated by the WHO CoP, ASPHER and Maastricht University. Summary of the first rapid assessment of the current state of the public health profession in the Czech Republic confirms the importance of further action in this area of work.

scholarly journals Laser toys fail to comply with safety standards – case study based on laser product classification

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Jaroslaw Mlynczak
Keyword(s):  
Public Health ◽  
Laser Safety ◽  
Safety Standards ◽  
The Public ◽  
Tests And Measurements ◽  
Radiation Sources ◽  
Product Classification

Abstract The article describes the laser safety classification of a laser toy for children equipped with a laser aimer/illuminator with two radiation sources. Following the rules presented in EN 60825-1: 2014 standard, the tests and measurements of the accessible emission were carried out and the class of the laser product was determined to be 3R. It was shown that the laser toy does not comply with the requirements of the EN 62115: 2020 standard and the Public Health England Guidance. The potential hazards associated with Class 3R, indicated in the EN 60825-1: 2014 standard, are also discussed.

scholarly journals Applicability of Phylogenetic Methods for Characterizing the Public Health Significance of Verocytotoxin-Producing Escherichia coli Strains

2007 ◽  
Vol 74 (5) ◽  
pp. 1671-1675 ◽  
Author(s):  
Kim Ziebell ◽  
Paulina Konczy ◽  
Irene Yong ◽  
Shelley Frost ◽  
Mariola Mascarenhas ◽  
...  
Keyword(s):  
Public Health ◽  
Escherichia Coli ◽  
Multiplex Pcr ◽  
Multilocus Sequence Typing ◽  
The Public ◽  
Phylogenetic Methods ◽  
Public Health Significance ◽  
Health Significance ◽  
Serious Disease

ABSTRACT Two phylogenetic methods (multilocus sequence typing [MLST] and a multiplex PCR) were investigated to determine whether phylogenetic classification of verocytotoxin-producing Escherichia coli serotypes correlates with their classification into groups (seropathotypes A to E) based on their relative incidence in human disease and on their association with outbreaks and serious complications. MLST was able to separate 96% of seropathotype D and E serotypes from those that cause serious disease (seropathotypes A to C), whereas the multiplex PCR lacked this level of seropathotype discrimination.

scholarly journals Excess Mortality in England during the 2019 Summer Heatwaves

Climate ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 14
Author(s):  
Natasha Rustemeyer ◽  
Mark Howells
Keyword(s):  
Public Health ◽  
United Kingdom ◽  
Excess Mortality ◽  
Summer Period ◽  
The Public ◽  
National Statistics ◽  
The United Kingdom ◽  
The Impact ◽  
Excess Deaths ◽  
Related Mortality

There is increasing evidence that rising temperatures and heatwaves in the United Kingdom are associated with an increase in heat-related mortality. However, the Public Health England (PHE) Heatwave mortality monitoring reports, which use provisional death registrations to estimate heat-related mortality in England during heatwaves, have not yet been evaluated. This study aims to retrospectively quantify the impact of heatwaves on mortality during the 2019 summer period using daily death occurrences. Second, using the same method, it quantifies the heat-related mortality for the 2018 and 2017 heatwave periods. Last, it compares the results to the estimated excess deaths for the same period in the PHE Heatwave mortality monitoring reports. The number of cumulative excess deaths during the summer 2019 heatwaves were minimal (161) and were substantially lower than during the summer 2018 heatwaves (1700 deaths) and summer 2017 heatwaves (1489 deaths). All findings were at variance with the PHE Heatwave mortality monitoring reports which estimated cumulative excess deaths to be 892, 863 and 778 during the heatwave periods of 2019, 2018 and 2017, respectively. Issues are identified in the use of provisional death registrations for mortality monitoring and the reduced reliability of the Office for National Statistics (ONS) daily death occurrences database before 2019. These findings may identify more reliable ways to monitor heat mortality during heatwaves in the future.

Baseline Rates of Campylobacter and Salmonella in Raw Chicken in Wales, United Kingdom, in 2002

2004 ◽  
Vol 67 (6) ◽  
pp. 1226-1228 ◽  
Author(s):  
R. J. MELDRUM ◽  
D. TUCKER ◽  
C. EDWARDS
Keyword(s):  
Public Health ◽  
United Kingdom ◽  
Seasonal Variation ◽  
Public Health Laboratory ◽  
Local Authorities ◽  
Laboratory Service ◽  
The Public ◽  
The United Kingdom ◽  
Food Standards ◽  
Similar Peak

The Public Health Laboratory Service in Wales, in cooperation with local authorities and the Food Standards Agency Wales, carried out a survey to establish baseline figures for the contamination of raw retail chicken with Salmonella and Campylobacter available within Wales, a devolved part of the United Kingdom with a population of ~3 million. Seven hundred thirty-nine samples were obtained between November 2001 and December 2002. Overall, 71% of samples were contaminated with Campylobacter, and 8% were contaminated with Salmonella. There were no significant differences between fresh and frozen carcasses and between samples taken from retailers or butchers. There was seasonal variation in the level of Campylobacter contamination of fresh chicken, with a peak in June and the lowest positive rates in January, March, and December. There was no similar peak observed in frozen samples or for Salmonella.

scholarly journals Excess Mortality in England During the 2019 Summer Heatwaves.

2020 ◽  
Author(s):  
Natasha Rustemeyer ◽  
Mark Howells
Keyword(s):  
Public Health ◽  
United Kingdom ◽  
Excess Mortality ◽  
Cumulative Number ◽  
Summer Period ◽  
The Public ◽  
The United Kingdom ◽  
The Impact ◽  
Excess Deaths ◽  
Related Mortality

There is increasing evidence that rising temperatures and heatwaves in the United Kingdom are associated with an increase in heat-related mortality. This study aims to retrospectively quantify the impact of heatwaves on mortality during the 2019 summer period using daily death occurrences. Second, it compares excess mortality during the 2019 heatwaves to excess mortality during the 2018 and 2017 heatwave periods. Lastly, it compares the excess mortality in the 2017-2019 heatwaves to the estimated excess deaths for the same period in the Public Health England (PHE) Heatwave mortality monitoring Reports. The cumulative number of excess deaths during the summer 2019 heatwaves were minimal and were substantially lower than during the summer 2018 heatwaves (1,700 deaths) and summer 2017 heatwaves (1,489 deaths). All findings were at variance with the PHE Heatwave mortality monitoring reports which estimated cumulative excess deaths to be 892, 863 and 778 during the summer period of 2019, 2018 and 2017 respectively using provisional death registrations. Issues have been identified in the use of provisional death registrations for mortality monitoring and the reduced reliability of the ONS daily death occurrence database before 2019. These findings may identify more reliable ways to monitor heat mortality during heatwaves in the future.

Sign in / Sign up

Export Citation Format

Share Document